Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of OCUL by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−17,768−100.0%Sold outHolders
Q2 202417,768$121.0K<0.1%00.0%UnchangedHolders
Q1 202417,768$163.0K<0.1%+1,630+10.1%AddedHolders
Q4 202316,138$72.0K<0.1%−4,000−19.9%ReducedHolders
Q3 202320,138$63.0K<0.1%−600−2.9%ReducedHolders
Q2 202320,738$107.0K<0.1%−330−1.6%ReducedHolders
Q1 202321,068$112.0K<0.1%00.0%UnchangedHolders
Q4 202221,068$59.0K<0.1%−700−3.2%ReducedHolders
Q3 202221,768$90.0K<0.1%00.0%UnchangedHolders
Q2 202221,768$87.0K<0.1%00.0%UnchangedHolders
Q1 202221,768$108.0K<0.1%+2,500+13.0%AddedHolders
Q4 202119,268$134.0K<0.1%+6,500+50.9%AddedHolders
Q3 202112,768$128.0K<0.1%+2,500+24.3%AddedHolders
Q2 202110,268$146.0K<0.1%−1,016−9.0%ReducedHolders
Q1 202111,284$185.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.